Clinical trial
Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected…
NCT00061243 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Unknown status
Key facts
| NCT number | NCT00061243 |
|---|---|
| Title | Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults |
| Official title | A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Multi-Gene, Polyvalent HIV-1 DNA Plasmid Prime/Env Protein Boost Vaccine Formulation, DP6-001 in Healthy Volunteers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | HIV-1 DNA vaccine with protein vaccine boost |
| Enrollment | 36 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2010 |
| First posted | May 23, 2003 |
| Last update posted | Sep 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: